# H-Type Hypertension Precision Medicine Trial

> **NCT03472508** · PHASE4 · UNKNOWN · sponsor: **Shenzhen Ausa Pharmed Co.,Ltd** · enrollment: 3600 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Folic Acid
- **DRUG:** Enalapril Maleate and Folic Acid Tablets (Yiye)
- **DRUG:** Enalapril

## Key facts

- **NCT ID:** NCT03472508
- **Lead sponsor:** Shenzhen Ausa Pharmed Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-20
- **Primary completion:** 2019-03-30
- **Final completion:** 2019-06-30
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2018-07-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03472508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03472508, "H-Type Hypertension Precision Medicine Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03472508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*